Fullerton Fund Management CO Ltd. Novartis Ag Transaction History

Fullerton Fund Management CO Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $220,151 - $256,116	-2,692 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $131,951 - $145,744	-1,548 Reduced 36.51%	2,692 $246,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $88,176 - $103,984	-1,056 Reduced 19.94%	4,240 $362,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $253,181 - $306,236	3,243 Added 157.96%	5,296 $500,000
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $168,633 - $186,823	2,053 New	2,053 $179,000

1,430

131M

1.12M

1.82M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $225B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Fullerton Fund Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Fullerton Fund Management CO Ltd. with notifications on news.